Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $68.6 Million - $83.3 Million
261,000 Added 131.02%
460,200 $144 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $53.6 Million - $64.7 Million
199,200 New
199,200 $56.6 Million
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $62.9 Million - $70 Million
-272,700 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $51.8 Million - $57.3 Million
236,400 Added 651.24%
272,700 $65.9 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $1.51 Million - $1.73 Million
7,600 Added 26.48%
36,300 $8.17 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $27.9 Million - $32.7 Million
-131,300 Reduced 82.06%
28,700 $6.1 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $27.9 Million - $32.5 Million
-125,700 Reduced 44.0%
160,000 $39.8 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $28.4 Million - $33.8 Million
131,300 Added 85.04%
285,700 $65.7 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $24.8 Million - $27.6 Million
105,800 Added 217.7%
154,400 $39.2 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $8.09 Million - $9.93 Million
-40,900 Reduced 45.7%
48,600 $11.5 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $12.4 Million - $16.4 Million
-68,000 Reduced 43.17%
89,500 $18.1 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $16.8 Million - $21.6 Million
-88,900 Reduced 36.08%
157,500 $38 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $42.9 Million - $51.4 Million
246,400 New
246,400 $47.7 Million
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $7.75 Million - $8.73 Million
-41,800 Closed
0 $0
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $6.94 Million - $7.8 Million
41,800 New
41,800 $7.72 Million
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $2.41 Million - $2.7 Million
-14,300 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $2.39 Million - $2.73 Million
14,300
14,300 $2.67 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.